CAPARELLO, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.568
AS - Asia 609
EU - Europa 540
SA - Sud America 76
AF - Africa 65
OC - Oceania 10
Totale 2.868
Nazione #
US - Stati Uniti d'America 1.530
SG - Singapore 193
CN - Cina 182
IT - Italia 138
DE - Germania 77
SE - Svezia 75
VN - Vietnam 71
GB - Regno Unito 70
HK - Hong Kong 66
BR - Brasile 62
BG - Bulgaria 44
CI - Costa d'Avorio 37
FR - Francia 35
CA - Canada 32
RU - Federazione Russa 28
FI - Finlandia 23
JP - Giappone 22
SN - Senegal 20
AT - Austria 16
IN - India 14
TR - Turchia 14
KR - Corea 12
BD - Bangladesh 10
AU - Australia 9
UA - Ucraina 9
NL - Olanda 8
IQ - Iraq 7
AR - Argentina 5
MA - Marocco 4
MX - Messico 4
ES - Italia 3
PL - Polonia 3
BE - Belgio 2
CO - Colombia 2
JO - Giordania 2
LT - Lituania 2
PK - Pakistan 2
RO - Romania 2
TW - Taiwan 2
VE - Venezuela 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MM - Myanmar 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 2.868
Città #
Ashburn 197
Woodbridge 167
Ann Arbor 142
Fairfield 118
Singapore 112
Houston 108
Santa Clara 95
Chandler 73
San Jose 72
Hong Kong 66
Beijing 52
Sofia 44
New York 39
Shanghai 39
Abidjan 37
Seattle 36
Cambridge 34
Princeton 31
Dallas 30
Los Angeles 30
Wilmington 30
Boardman 29
London 27
Frankfurt am Main 25
Lancaster 24
Ottawa 24
Pisa 22
Dakar 20
Florence 19
Ho Chi Minh City 18
Lawrence 18
Dearborn 17
Tokyo 16
Des Moines 15
Serra 15
Medford 14
Munich 14
Vienna 14
Düsseldorf 12
Lauterbourg 12
Helsinki 11
Hanoi 8
Istanbul 8
Nanjing 8
Redondo Beach 8
Shenyang 8
Fuzhou 7
Rome 7
Buffalo 6
Iowa City 6
Columbus 5
Hebei 5
Milan 5
Wuhan 5
Baghdad 4
Chennai 4
Council Bluffs 4
Denver 4
Phoenix 4
Redwood City 4
Bremen 3
Chengdu 3
Dhaka 3
Hefei 3
Nuremberg 3
Pistoia 3
Rio de Janeiro 3
San Diego 3
Seacroft 3
Strasbourg 3
Toronto 3
Warsaw 3
Amman 2
Bến Tre 2
Canino 2
Contagem 2
Dong Ket 2
Foz do Iguaçu 2
Goiânia 2
Grafing 2
Guangzhou 2
Haiphong 2
Jiaxing 2
João Pessoa 2
Liverpool 2
Massa 2
Montreal 2
Montréal 2
Ninh Bình 2
Norwalk 2
Orem 2
Osaka 2
Perth 2
Poplar 2
Positano 2
Pune 2
Ribeirão das Neves 2
Savona 2
Seoul 2
São Paulo 2
Totale 2.120
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 323
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 199
Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer? 183
Second-line therapy for advanced pancreatic cancer: Evaluation of prognostic factors and review of current literature 176
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer 174
First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors 174
Correlation between LDH levels and response to sorafenib in HCC patients: An analysis of the ITA.LI.CA database 170
Tolerability of FOLFOXIRI regimen after surgical resection for pancreatic cancer. 166
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected adenocarcinomas of the stomach and gastro-esophageal junction 159
Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data 157
Multicenter Prospective Study of Angiogenesis Polymorphism Validation in HCC Patients Treated with Sorafenib. An INNOVATE Study Protocol 152
Prognostic model for patients (PTS) with advanced pancreatic cancer (aPC) receiving first-line modified FOLFIRINOX (Mfolfirinox) 146
Second-line chemotherapy (CT2) in advanced biliary tract cancer (aBTC) patients (PTS) progressed to first-line chemotherapy (CT1) with gemcitabine plus platinum: where are we now? 138
Comment on: 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: An AGEO prospective multicentre cohort' 136
Palliative gastrectomy in asymptomatic metastatic esophagogastric cancer (EGC): does it make sense? 132
Pharmacoepigenetics in gastrointestinal tumors: MGMT methylation and beyond 128
Single-centre experience with third-line chemotherapy with irinotecan plus 5-fluorouracil and leucovorin (FOLFIRI) in metastatic gastric cancer patients. 116
Early changes in plasma levels of mutant KRAS DNA as a sensitive marker of response to chemotherapy in pancreatic cancer 93
Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival 3
Totale 2.925
Categoria #
all - tutte 8.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 3 23
2021/2022193 2 6 4 5 43 24 8 6 11 5 16 63
2022/2023301 25 56 20 12 20 33 2 8 90 3 27 5
2023/2024152 5 10 20 2 23 33 19 7 1 6 9 17
2024/2025547 0 19 20 27 65 75 32 6 40 65 68 130
2025/2026602 69 53 22 40 135 35 105 20 41 64 18 0
Totale 2.925